CHAPTER 1INTRODUCTION

1.1 Report Description
1.2 Reason for doing study
1.3 Key Benefits
1.4 Key Market Segments
1.5 Key Audiences
1.6 Research Methodology

1.6.1 Secondary research
1.6.2 Primary research
1.6.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO Perspective
2.2 Market beyond: What to expect by 2025

2.2.1 Moderate Growth Scenario
2.2.2 Rapid growth Scenario
2.2.3 Diminishing growth scenario

CHAPTER 3 GLOBAL ADVANCED WOUND CARE AND WOUND CLOSURE MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Treatment  of diabetic foot ulcers with Negative Pressure Wound Therapy using vaccum-assisted closure and  advanced moist wound therapy
3.3 Emergence of combination dressings
3.4 Biologics : An emerging area of Advanced wound care
3.5 Key Findings

3.5.1 Top factors impacting Global Advanced Wound closure and  wound care market
3.5.2 Top winning strategies in the  Global Advanced wound closure and wound care market
3.5.3 Top investment pockets in advanced wound closure and wound care market

3.6 Value chain analysis
3.7 Porter’s five forces analysis
3.8 Market share analysis, 2013
3.9 Case Studies

3.9.1 Use of IntraSite Conformable dressing in the management of a sloughy venous leg ulcer
3.9.2 IntraSite Conformable in the treatment of necrotic pressure ulcers

3.9.3 INTEGRA WOUND MATRIX DRESSINGS IN TYPE II DIABETIC ULCER

3.10 Global advanced wound care and wound closure market Dynamics

3.10.1 Drivers

3.10.1.1 Increase in aging population
3.10.1.2 Rise in prevalence of chronic wounds, venous ulcers,diabetic ulcers and pressure sores
3.10.1.3 Advancement in technology
3.10.1.4 Increase in volume of Surgeries

3.10.2 Restraints

3.10.2.1 Unfavourable reimbursement policies
3.10.2.2 reluctance in adoption of New technologies

3.10.3 Opportunities

3.10.3.1 Advancements in Moist dressing
3.10.3.2 Optimised physical therapies
3.10.3.3 Biological products

CHAPTER 4 ADVANCED WOUND CARE AND WOUND CLOSURE MARKET BY TYPES

4.1 Advanced Wound Closure

4.1.1 Key market trends
4.1.2 Key drivers and opportunities
4.1.3 Market size and forecast
4.1.4 Haemostatic and sealing agent

4.1.4.1 Surgical Sealant
4.1.4.2 Fibrin Sealant
4.1.4.3 Gelatin-based sealant
4.1.4.4 Human fibrinogen and thrombin fleece (HFTF)

4.1.5 Topical tissue adhesive
4.1.6 Wound closure devices

4.1.6.1 Mechanical Stapling device
4.1.6.2 Ligating clips
4.1.6.3 Wound Closure Strips
4.1.6.4 Others

4.2 Advanced Wound care

4.2.1 Key market trends
4.2.2 Key drivers and opportunities
4.2.3 Market size and forecast
4.2.4 Moist Wound dressings

4.2.4.1 Films

4.2.4.2 Foams
4.2.4.3 Hydrocolloids
4.2.4.4 Hydrogels
4.2.4.5 Collagen
4.2.4.6 Alginate Dressings
4.2.4.7 Silver wound dressings

4.2.5 Active Wound care

4.2.5.1 Skin Substitutes
4.2.5.2 Growth Factors

4.2.6 Therapy devices

4.2.6.1 Negative Pressure wound therapy
4.2.6.2 Pressure Relief devices
4.2.6.3 Others

CHAPTER 5 GLOBAL ADVANCED WOUND CARE AND ADVANCED WOUND CLOSURE MARKET BY APPLICATION

5.1 Burns
5.2 Ulcers

5.2.1 Pressure ulcers
5.2.2 Diabetic foot Ulcers
5.2.3 Venous Ulcers
5.2.4 Arterial Ulcers

5.3 Surgical Wounds
5.4 Others

CHAPTER 6 GLOBAL ADVANCED WOUND CARE AND WOUND CLOSURE MARKET BY END USER

6.1 Hospitals & Community Health Services
6.2 Home Healthcare

CHAPTER 7 GLOBAL ADVANCED WOUND CARE AND WOUND CLOSURE MARKET BY GEOGRAPHY

7.1 North America

7.1.1 Key Market Trends
7.1.2 Competitive Scenario
7.1.3 Key growth factors and opportunities
7.1.4 Market size and Forecast

7.2 Europe

7.2.1 Key market trends
7.2.2 Competitive Scenario
7.2.3 Key growth factors and opportunities
7.2.4 Market Size and Forecast

7.3 Asia Pacific

7.3.1 Key market trends
7.3.2 Competitive Scenario
7.3.3 Key growth factors and opportunities
7.3.4 Market Size and Forecast

7.4 LAMEA

7.4.1 Key market trends
7.4.2 Competitive Scenario
7.4.3 Key growth factors and opportunities
7.4.4 Market Size and Forecast

CHAPTER 8 COMPANY PROFILE

8.13 M

8.1.1 Company overview
8.1.2 Company Snapshot
8.1.3 Business Performance
8.1.4 Strategy move and development
8.1.5 SWOT Analysis of 3M

8.2 BSN Medical

8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Strategic move and development
8.2.4 SWOT Analysis of BSN Medical

8.3 Covidien

8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Business Performance
8.3.4 Strategic move and development
8.3.5 SWOT Analysis of Covidien

8.4 Kinetic Concepts

8.4.1 Company Overview
8.4.2 Company snapshot
8.4.3 Business performance
8.4.4 Strategic move and development

8.4.4.1 Primary Strategy: Product launch
8.4.4.2 Secondary Strategy : Acquisition

8.4.5 SWOT Analysis of Kinetic Concepts

8.5 ConvaTech

8.5.1 Company Overview
8.5.2 Company Snapshot
8.5.3 Business Performance
8.5.4 Strategic move and development

8.5.4.1 Principle strategy Product launch
8.5.4.2 Secondary strategy Acquisitions

8.5.5 SWOT Analysis ConvaTech

8.6 Coloplast

8.6.1 Company Overview
8.6.2 Company Snapshot
8.6.3 Business Performance
8.6.4 Strategic move and development
8.6.5 SWOT Analysis of Coloplast

8.7 Derma Sciences

8.7.1 Company overview
8.7.2 Company snapshots
8.7.3 Business Performance
8.7.4 Strategy move and development

8.7.4.1 Principle strategy: Product launch
8.7.4.2 Secondary strategy: Acquisition

8.7.5 SWOT Analysis of Derma Sciences

8.8 Integra LifeSciences

8.8.1 Company overview
8.8.2 Company Snapshot
8.8.3 Business performance
8.8.4 Strategic move and development

8.8.4.1 Principle strategy product launch
8.8.4.2 Secondary strategy acquisition

8.8.5 SWOT Analysis of Integra LifeSciences

8.9 Baxter International

8.9.1 Company Overview
8.9.2 Company Snapshot
8.9.3 Business Performance
8.9.4 Strategic move and development

8.9.4.1 Principle strategy:p product launch
8.9.4.2 Secondary strategy: Research and development

8.9.5 SWOT Analysis of Baxter International

8.10 Smith & Nephews

8.10.1 Company Overview
8.10.2 Company Snapshot
8.10.3 Business Performance
8.10.4 Strategic move and development

8.10.4.1 Principle strategy Product launch
8.10.4.2 Secondary Strategy Acquisitions

List of Tables

TABLE 1  BASE CASE ADVANCED WOUND CARE AND WOUND CLOSURE  MARKET REVENUE BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 2  OPTISMITICS CASE ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 3  CRITICAL CASE ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 4  GLOBAL ADVANCED WOUND CLOSURE MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 5  GLOBAL HAEMOSTATICS AND SEALING ADVANCED WOUND CLOSURE MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 6  GLOBAL HAEMOSTATICS AND SEALING ADVANCED WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 7  GLOBAL SURGICAL HAEMOSTATICS AND SEALING AGENTS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 8  GLOBAL FIBRIN HAEMOSTATICS AND SEALING AGENTS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 9  GLOBAL GELATIN-BASED HAEMOSTATICS AND SEALING AGENTS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 10  GLOBAL HFTF HAEMOSTATICS AND SEALING AGENTS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 11  GLOBAL TOPICAL TISSUE ADHESIVES ADVANCED WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 12  GLOBAL WOUND CLOSURE DEVICES MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 13  GLOBAL WOUND CLOSURE DEVICES MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 14  GLOBAL MECHANICAL STAPLING WOUND CLOSURE DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 15  GLOBAL LIGATING CLIPS WOUND CLOSURE DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 16  GLOBAL WOUND CLOSURE STRIPS WOUND CLOSURE DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 17  GLOBAL OTHERS WOUND CLOSURE DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 18  GLOBAL ADVANCED WOUND CLOSURE MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 19  GLOBAL ADVANCED WOUND CARE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 20  GLOBAL FILMS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 21  GLOBAL FOAMS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 22  GLOBAL HYDROCOLLOIDS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 23  GLOBAL HYDROGELS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 24  GLOBAL COLLAGENS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 25  GLOBAL ALGINATE DRESSINGS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 26  GLOBAL SILVER WOUND DRESSINGS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 27  GLOBAL ACTIVE WOUND CARE MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 28  GLOBAL ACTIVE WOUND CARE MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 29  GLOBAL SKIN SUBSTITUTES ACTIVE WOUND CARE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 30  GLOBAL GROWTH FACTORS ACTIVE WOUND CARE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 31  GLOBAL THERAPYDEVICE MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 32  GLOBAL THERAPY DEVICE  MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION
TABLE 33  GLOBAL NPWT THERAPY DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 34  GLOBAL PRESSURE RELIEF  THERAPY DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 35  GLOBAL NPWT THERAPY DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 36  GLOBAL ADVANCED WOUND CLOSURE AND WOUND CARE  MARKET REVENUE BY APPLICATION, 2013-2020 ($MILLION)
TABLE 37  GLOBAL BURNS ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 38  GLOBAL ULCERS ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY TYPE, 2013 – 2020 ($MILLION)
TABLE 39  GLOBAL ULCERS ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 40  GLOBAL PRESSURE ULCERS APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 41  GLOBAL DIABETIC FOOT ULCERS APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 42  GLOBAL VENOUS ULCERS APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 43  GLOBAL ARTERIAL ULCERS APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 44  GLOBAL SURGICAL WOUNDS ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 45  GLOBAL SURGICAL WOUNDS APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 46  GLOBAL OTHER APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 47  GLOBAL ADVANCED WOUND CLOSURE AND WOUND CARE  MARKET REVENUE BY AN, 2013-2020 ($MILLION)
TABLE 48  GLOBAL ADVANCED WOUND CLOSURE AND WOUND CARE END USER  MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 49  GLOBAL HOSPITALS & CHS END USER MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 50  GLOBAL HOME HEALTHCARE END USER MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 51  NORTH AMERICA ADVANCED WOUND CARE AND WOUND CLOSURE  MARKET REVENUE BY APPLICATION, 2013-2020 ($MILLION)
TABLE 52  EUROPE ADVANCED WOUND CARE AND WOUND CLOSURE  MARKET REVENUE BY APPLICATION, 2013-2020 ($MILLION)
TABLE 53  ASIA-PACIFIC ADVANCED WOUND CARE AND WOUND CLOSURE  MARKET REVENUE BY APPLICATION, 2013-2020 ($MILLION)
TABLE 54  LAMEA ADVANCED WOUND CARE AND WOUND CLOSURE  MARKET REVENUE BY APPLICATION, 2013-2020 ($MILLION)
TABLE 55  3M SNAPSHOT
TABLE 56  BSN SNAPSHOT
TABLE 57  COVIDIEN SNAPSHOT
TABLE 58  KINETIC CONCEPTS SNAPSHOT
TABLE 59  CONVATECH SNAPSHOT
TABLE 60  COLOPLAST SNAPSHOT
TABLE 61  DERMASCIENCES SNAPSHOT
TABLE 62  INTEGRA LIFESCIENCES SNAPSHOT
TABLE 63  BAXTER SNAPSHOT

List of Figures

FIG. 1  TOP IMPACTING FACTOR (2020-2025)
FIG. 2  TOP IMPACTING FACTORS, OPTIMISTIC CASE (2020-2025)
FIG. 3  TOP IMPACTING FACTOR, CRITICAL CASE (2020-2025)
FIG. 4  TOP FACTORS IMPACTING GLOBAL ADVANCED WOUND CLOSURE AND WOUND CARE MARKET, 2013-2020
FIG. 5  TOP WINNING STRATEGIES IN GLOBAL ADVANCED WOUND CLOSURE AND WOUND CARE MARKET, 2013-2020
FIG. 6  VALUE CHAIN ANALYSIS
FIG. 7  PORTER’S FIVE FORCES ANALYSIS
FIG. 8  3M REVENUE BY BUSINESS SEGMENTS
FIG. 9  3M REVENUE BY GEOGRAPHY
FIG. 10  SWOT ANALYSIS OF 3M
FIG. 11  SWOT  ANALYSIS OF BSN MEDICAL
FIG. 12  COVIDIEN REVENUE BY BUSINESS SEGMENTS
FIG. 13  COVIDIEN REVENUE BY GEOGRAPHY
FIG. 14  SWOT ANALYSIS OF COVIDIEN
FIG. 15  KINETIC CONCEPTS REVENUE BY BUSINESS SEGMENT
FIG. 16  SWOT ANALYSIS OF KINETIC CONCEPTS
FIG. 17  CONVATECH REVENUE BY BUSINESS SEGMENTS
FIG. 18  SWOT OF CONVATECH
FIG. 19  COLOPLAST REVENUE BY BUSINESS SEGMENTS
FIG. 20  DERMA SCIENCES REVENUE BY BUSINESS SEGMENTS
FIG. 21  SWOT ANALYSIS OF DERMA SCIENCES
FIG. 22  REVENUE BY GEOGRAPHY
FIG. 23  INTEGRA LIFESCIENCES REVENUE BY SEGMENTS IN US
FIG. 24  SWOT ANALYSIS OF INTEGRA LIFESCIENCES
FIG. 25   BAXTER INTERNATIONAL REVENUE BY BUSINESS SEGMENTS
FIG. 26 BAXTER INTERNATIONAL REVENUE BY GEOGRAPHY
FIG. 27 SWOT ANALYSIS OF BAXTER INTERNATIONAL
FIG. 28 SMITH & NEPHEWS REVENUE BY BUSINESS SEGMENTS
FIG. 29 SMITH & NEPHEWS REVENUE BY GEOGRAPHY
FIG. 30 SWOT OF SMITH AND NEPHEWS

Advanced wound care and closure products have emerged as the promising solution in wound management. Wound closure devices, Haemostatic and sealing agents, and topical adhesives has proven their effectiveness in wound closing over traditional sutures and stapling wound closures as these advanced wound closures support scar free surgeries and offer number of benefits over conventional solutions. Moist wound dressings and composite dressings has changed the wound healing process. Traditional dressings are being increasingly substituted with moist and composite wound dressings, mainly due to their effectiveness in managing wounds by promoting faster healing. Active wound care has emerged as a most potent segment of advanced wound care and would become most preferable solution for wound management. Therapy devices such as Negative Pressure Wound Therapy systems, Pressure relief devices and other devices under clinical studies are the noval approach in the wound management. Rising lifestyle diseases that lead to chronic wounds such as diabetic foot ulcers and growing number of cosmetic, plastic and other surgical procedures has boosted the market growth. However, Reimbursement for advanced wound care and wound closure products is complex as these products are very expensive and experiencing significant price pressures.